C-Path using Rosetta's Resolver in predictive safety testing consortium

NEW YORK (GenomeWeb News) -- The Critical Path Institute will use Rosetta Biosoftware’s Resolver system, Rosetta said today. C-Path will use the software for data management and analysis in its Predictive Safety Testing Consortium, which is a collection of pharmaceutical companies that work with C-Path to share information that may help improve drug safety.

C-Path is a publicly funded research and education institute in Tuscon, Ariz., and is a research arm of the US Food and Drug Administration’s Critical Path Initiative. Financial terms of the deal were not released.